PS Ratio: 95.27

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 95.27 is 25% below its estimated 1-year average of 127.87, near the low end of its estimated 1-year range (95.27–148.75).

As of 2026-10-06T19:55:35.689Z.

AKTS PS Ratio Metrics

P/S vs. estimated history

At 95.27, P/S is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 1-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Aktis Oncology, Inc. (AKTS)?

The P/S ratio for AKTS stock is 95.27.

Is Aktis Oncology, Inc.'s P/S ratio high or low?

The P/S ratio of 95.27 is 25% below its estimated 1-year average of 127.87, near the low end of its estimated 1-year range (95.27–148.75).

Related Metrics